EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.

Kulveer Mankia Heidi J Siddle Andreas Kerschbaumer Deshiré Alpizar-RodriguezAnca Irinel CatrinaJuan D CañeteAndrew P CopeClaire Immediato DaienKevin D DeaneHani El GabalawyAxel FinckhV Michael HolersMarios KoloumasFrancesca OmettoKarim RazaCondruta ZabalanAnnette H M van der Helm van MilDirkjan van SchaardenburgDaniel Aletaha Paul Emery

Published in: Annals of the rheumatic diseases (2021)

These consensus statements provide data-driven guidance for rheumatologists, health professionals and investigators conducting clinical trials and observational studies in individuals at risk of RA.

Keyphrases

clinical trial
rheumatoid arthritis
disease activity
phase ii
ankylosing spondylitis
interstitial lung disease
open label
phase iii
study protocol
systemic lupus erythematosus